InvestorsHub Logo
Followers 7
Posts 289
Boards Moderated 0
Alias Born 12/11/2013

Re: sox040713 post# 183449

Sunday, 05/28/2017 9:46:35 AM

Sunday, May 28, 2017 9:46:35 AM

Post# of 402816
Seems to me we ought to be able to charge more for Brilacidin than Kepivance since it will be much more effective...."In people undergoing total body irradiation for a stem cell transplant, 63% receiving Kepivance® developed grade 3 or 4 (severe) oral mucositis compared to 98% of those not receiving Kepivance.®"

http://kepivance.typo3konsult.se/patients/about-kepivance/about-kepivancer/

What would be reasonable 25% more, so $5 Billion/yr becomes $6 Billion/yr sales potential? I really like our odds here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News